BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10689876)

  • 1. [The result of mass screening of 1997 for prostatic cancer in Isesaki City].
    Kobayashi M; Takezawa Y; Nakata S; Inoue M; Kurihara H; Kondo T; Kosaku N; Matsumoto K; Nakazato H; Yamanaka H
    Nihon Hinyokika Gakkai Zasshi; 2000 Jan; 91(1):1-7. PubMed ID: 10689876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass screening for prostate cancer in Tokushima City: the results of 2001].
    Kanayama HO; Kagawa S; Utsunomiya M; Kawashima S; Takehisa I; Sumitani H; Yokozeki H
    Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):596-603. PubMed ID: 15103922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of early detection for prostate cancer in mass screening].
    Kato M; Tammbo M; Yoshimatsu T; Ohta M; Kinjyo M; Noda H; Watanabe K; Miyata A; Murata A; Miura I; Yoneda T; Yoshii M; Okegawa T; Kojima M; Sayama T; Nutahara K; Higashihara E
    Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):23-9. PubMed ID: 11235139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
    Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass screening of prostate cancer in Changchun City of China.
    Li X; Tsuji I; Kuwahara M; Zhang H; Wang H; Zhang L; Ji G; Zhao X
    Int Urol Nephrol; 2004; 36(4):541-8. PubMed ID: 15787333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
    Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
    Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of PSA screening in outpatients with bladder cancer: preliminary results.
    Kurokawa K; Suzuki K; Okazaki H; Ito K; Shiono A; Fukabori Y; Yamanaka H
    Int J Urol; 2002 May; 9(5):237-40. PubMed ID: 12060434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
    Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
    Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
    Tsui KH; Chang PL; Wang TM; Hsieh ML
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
    Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
    Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam).
    Beemsterboer PM; Kranse R; de Koning HJ; Habbema JD; Schröder FH
    Int J Cancer; 1999 Aug; 84(4):437-41. PubMed ID: 10404100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of prostate-specific antigen as part of the diagnostic triad and as a guide when to perform a biopsy.
    Babaian RJ; Camps JL
    Cancer; 1991 Nov; 68(9):2060-3. PubMed ID: 1717134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.
    Bazinet M; Meshref AW; Trudel C; Aronson S; Péloquin F; Nachabe M; Bégin LR; Elhilali MM
    Urology; 1994 Jan; 43(1):44-51; discussion 51-2. PubMed ID: 7506853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination.
    Vallancien G; Prapotnich D; Veillon B; Brisset JM; Andre-Bougaran J
    J Urol; 1991 Nov; 146(5):1308-12. PubMed ID: 1719243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of serum prostate-specific antigen in hemodialysis patients.
    Sumura M; Yokogi H; Beppu M; Honda H
    Int J Urol; 2003 May; 10(5):247-50. PubMed ID: 12694463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.